Skeletal Muscle Properties and the Metabolic Cost of Walking Post-stroke

Completed

Phase 2 Results

Summary of Purpose

Of the ~700,000 persons who suffer a stroke each year, only 50% recover the ability to perform unlimited community walking. One mechanism contributing to locomotor dysfunction post-stroke is an increased metabolic cost of walking relative to neurologically healthy individuals 2-4. This increased cost likely limits the amount of walking performed, which further reduces functional capacity, thus contributing to...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 July 2015.

1 Aug 2008 21 Jul 2008 1 Jul 2012 1 Sep 2013 1 Jul 2015 8 Jan 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Cross-Sectional
  • Sampling: Probability Sample

Contacts